National Health Investors focuses on senior housing portfolio as REIT strategy evolves
National Health Investors (NHI) is a US healthcare REIT that concentrates on owning and financing senior housing and healthcare properties. The company aims to benefit from the growing demand for assisted living, memory care, and skilled nursing facilities due to the aging US population. NHI's strategy focuses on stable rental income, long-term tenant relationships, and prudent capital allocation within its portfolio of senior housing and skilled nursing assets.
NHI - National Health Investors Inc Volatility & Greeks
This article provides a detailed financial overview of National Health Investors Inc. (NHI), including its latest stock performance, volatility, key financial ratios, insider and institutional ownership, and general market data. It highlights the company's valuation metrics, dividend information, and various performance indicators over different periods.
NATIONAL HEALTH INVESTORS (NHI) CFO discloses initial stock and option stakes
NATIONAL HEALTH INVESTORS (NHI) CFO Todd Michael Siefert has reported his initial holdings in the company via a Form 3 filing. He directly owns 3,048 shares of common stock and holds three stock option awards for a total of 50,000 underlying shares, each with an exercise price of $71.76 expiring on June 1, 2031. Additionally, a restricted stock grant will vest in three equal annual installments starting June 1, 2027, contingent on his continued service.
National Health Investors, Inc. (NHI) Files 8-K for Change in Control Severance Agreement with CFO Todd Siefert
National Health Investors, Inc. (NHI) has filed an 8-K detailing a Change in Control Severance Agreement with CFO Todd Siefert, effective July 1, 2026. This agreement aims to secure the CFO's continued service and objectivity during potential changes in company control, providing severance benefits if his employment is terminated without "Cause" or he resigns for "Good Reason" following such an event. While indicating no immediate change in control, the agreement outlines substantial financial implications for the company and includes restrictive covenants for the CFO.
NHC Completes Acquisition of Thirty-Five NHI Facilities
National Healthcare Corporation (NHC) has completed the acquisition of real estate for 32 skilled nursing facilities and three independent living facilities from National Health Investors, Inc. (NHI) for $560 million. This acquisition, which includes properties NHC had previously leased and operated, is expected to enhance long-term returns, earnings, and cash flow by providing NHC with greater operational control. The facilities are located across Alabama, Florida, Kentucky, Missouri, South Carolina, Tennessee, and Virginia, strengthening NHC's existing asset portfolio and continuum of care in these regions.
NHI (NYSE: NHI) closes $560M sale of 35 senior care facilities to NHC affiliates
National Health Investors (NHI) has completed the sale of 32 skilled nursing facilities and three independent living facilities to affiliates of National HealthCare Corporation (NHC) for $560 million. This transaction converted a long-standing master lease arrangement into an ownership transfer. A Special Committee of independent directors approved the related-party deal, and the master lease was terminated for all but four Florida facilities, which were assigned to an NHC subsidiary.
National Health Investors (NHI) sets change in control severance terms for CFO
National Health Investors (NHI) has approved a new change in control severance agreement for its Chief Financial Officer, Todd Siefert, effective July 1, 2026. This agreement provides significant protections including lump-sum payments, continued health coverage, and full vesting of equity awards if his employment is terminated without cause or if he resigns for good reason in relation to a change in control. In return, Siefert is bound by non-compete, non-solicitation, and confidentiality clauses.
NHC/OP, L.P. completed the acquisition of Real Estate of 32 Skilled Nursing Facilities and 3 Independent Living Facilities from National Health Investors, Inc..
NHC/OP, L.P. has completed the acquisition of the real estate of 32 skilled nursing facilities and 3 independent living facilities from National Health Investors, Inc. for $560 million. The transaction, which was approved by a Special Committee of NHI, closed on July 1, 2026, and the properties are located across several states. National Healthcare Corporation will continue to operate most of these facilities, with four Florida skilled nursing facilities remaining under a third-party operator's lease.
Deutsche Bank Maintains National Health Investors Inc(NHI.US) With Hold Rating, Cuts Target Price to $80
Deutsche Bank has reiterated its Hold rating on National Health Investors Inc (NHI.US), while simultaneously reducing its target price for the stock to $80. This adjustment by the analyst firm suggests a revised outlook on the real estate investment trust specializing in healthcare properties.
National Health Investors Inc To Go Ex-Dividend On June 30th, 2026 With 0.92 USD Dividend Per Share
National Health Investors Inc. (NHI) is scheduled to go ex-dividend on June 30th, 2026. Shareholders will receive a dividend of $0.92 per share. This declaration indicates the company's commitment to returning value to its investors.
National Health Investors, Inc.(NYSE:NHI) dropped from Russell Small Cap Comp Growth Benchmark
National Health Investors, Inc. (NYSE: NHI) has been removed from the Russell Small Cap Comp Growth Benchmark, as announced on June 28, 2026. This news follows a series of related index removals including the Russell 3000E Growth Benchmark, Russell 3000 Growth Benchmark, Russell 2500 Growth Benchmark, and Russell 2000 Growth Benchmark on the same date. The company also recently completed a $560 million sale of 35 healthcare facilities.
SG Americas Securities LLC Grows Position in National Health Investors, Inc. $NHI
SG Americas Securities LLC significantly increased its stake in National Health Investors, Inc. (NYSE:NHI) by 818.3% in the first quarter, now holding 110,587 shares valued at $8.94 million. The company reported mixed quarterly results and announced a quarterly dividend of $0.92 per share, while institutional ownership stands at 62.51%. Analysts currently rate NHI as a "Moderate Buy" with a consensus price target of $83.86.
Does NHI’s Russell Growth Index Exit Reveal a Shift in Its Senior Housing Investment Profile?
National Health Investors (NHI) was removed from several Russell growth indices in late June 2026, which may cause mechanical selling by index-tracking funds and alter its perception in growth portfolios. While this reshuffle could influence short-term trading, the article emphasizes that the core investment narrative for NHI still revolves around stabilizing occupancy in its senior housing portfolio and managing risks like tenant concentration and financing future investments, especially given a recent US$500 million equity filing. Investors are encouraged to focus on NHI's fundamental outlook, including projected revenue and earnings, and consider other perspectives and fair value estimates.
National Health Investors, Inc.(NYSE: NHI) dropped from Russell 3000 Growth Benchmark
National Health Investors, Inc. (NYSE: NHI) has been removed from the Russell 3000 Growth Benchmark. This news follows a series of recent analyst price target adjustments and an announcement that the company is set to join the S&P SmallCap 600 Index. NHI also recently reported its Q1 2026 earnings, posting increased normalized FFO and revenue, alongside a lowered full-year guidance and an announced dividend.
National Health Investors, Inc. (NYSE:NHI) Receives Average Recommendation of "Moderate Buy" from Brokerages
National Health Investors, Inc. (NYSE:NHI) has received an average "Moderate Buy" recommendation from eight brokerage firms, with an average 12-month target price of $84.57. Recent insider buying by Director Robert A. McCabe Jr. and CEO D. Eric Mendelsohn increased their stakes, while the company declared a quarterly dividend of $0.92 per share, yielding 4.9% with a payout ratio of 118.71%. The article also details recent analyst ratings, institutional investor activity, and the company's financial performance.
Price to earnings forward of National Health Investors, Inc. – SWB:WX6
This article provides the "Price to earnings forward" value for National Health Investors, Inc. (SWB:WX6) on the Stuttgart Stock Exchange. It indicates that the market is currently closed with no trades. The content is primarily a data point surrounded by TradingView platform navigation and copyright information.
(NHI) Movement as an Input in Quant Signal Sets
This article provides an in-depth quantitative analysis of National Health Investors Inc. (NYSE: NHI) as an input for quant signal sets. It highlights strong sentiment supporting an overweight bias, outlines three AI-generated institutional trading strategies (Position, Momentum Breakout, and Risk Hedging), and details multi-timeframe signal analysis with support and resistance levels. The analysis aims to help optimize position sizing and minimize drawdown risk.
The NHI Senior Housing Net Lease from National Health Investors Inc. - long-term leases and stable cash flows
The NHI Senior Housing Net Lease, a portfolio product from National Health Investors Inc., involves long-term triple-net leases for assisted-living and memory-care communities. This strategy provides stable cash flows for investors by bundling properties under master agreements with regional operators, who handle property taxes, insurance, and maintenance. NHI actively manages this portfolio through asset sales and refinancing to enhance quality and capitalize on demographic trends, offering a capital-light solution for operators and a stable income stream for investors.
National Health Investors, Inc. Actuals & Estimates (NYSE:NHI)
This article provides an overview of National Health Investors, Inc. (NYSE: NHI), including its current stock price, historical performance, analyst forecasts, and financial data. It details NHI's market capitalization, earnings per share, revenue, net income, dividends, and other key financial metrics. The article also addresses frequently asked questions about investing in NHI stock.
Deutsche Bank Adjusts National Health Investors Price Target to $80 From $85, Maintains Hold Rating
Deutsche Bank has adjusted its price target for National Health Investors (NHI) to $80, down from $85, while maintaining a Hold rating on the stock. This update reflects a change in the bank's outlook for the specialized REIT, impacting investor sentiment. National Health Investors is a real estate investment trust focused on senior housing and medical investments.
Toast, IES Holdings and National Health stocks rise on S&P index adds
Shares of Toast Inc., IES Holdings Inc., and National Health Investors Inc. rose in premarket trading after S&P Dow Jones Indices announced their inclusion in various S&P indices. Toast and IES Holdings will join the S&P MidCap 400, while National Health Investors will be added to the S&P SmallCap 600. These changes are expected to lead to increased buying from index funds tracking these benchmarks.
National Health Investors (NHI) Proxy Filing Summary
National Health Investors (NHI) experienced significant growth in 2024, outperforming its index with increased Nareit FFO, Normalized FFO, and Funds Available for Distribution. The company invested over $235 million and raised $262 million in equity, while also optimizing its portfolio and improving leverage. For 2025, the company has already closed $136.4 million in real estate investments and anticipates continued growth, with key voting matters for shareholders including director elections, board declassification, executive compensation, and ratification of its independent auditor.
National Health Investors Inc (NHI) Technical Analysis: Support, Resistance, Indicators & Moving Averages
This article provides a technical analysis of National Health Investors Inc (NHI), detailing its current price momentum, support and resistance levels, and signals from various technical indicators and moving averages. NHI currently has a price momentum score of 7.07, ranking 69th in its industry, and is trading within a range suitable for swing trading. The analysis indicates a "Sell" signal based on a combination of different indicators and moving averages.
Liquidity Mapping Around (NHI) Price Events
This report from Stock Traders Daily provides a liquidity mapping analysis for National Health Investors Inc. (NHI), highlighting divergent sentiment and elevated downside risk. It includes AI-generated institutional trading strategies for position trading, momentum breakout, and risk hedging, along with a multi-timeframe signal analysis. The analysis suggests choppy conditions and advises caution due to a lack of long-term support signals.
BMO Capital Maintains National Health Investors Inc(NHI.US) With Buy Rating, Cuts Target Price to $80
BMO Capital has reiterated its 'Buy' rating for National Health Investors Inc (NHI.US) but has reduced its target price to $80. This adjustment reflects BMO Capital's updated outlook for the company, while still maintaining a positive investment recommendation.
Insider Buying: MCCABE ROBERT A JR Acquires Shares in National H
Director MCCABE ROBERT A JR recently purchased 890 shares of National Health Investors Inc (NHI), increasing his total holdings to 44,158.96 shares. This transaction reflects a positive insider sentiment, with two insider buys and no sells over the last year. The stock is currently trading at $71.65, and its GF Value suggests it is modestly undervalued at $80.24.
National health investors director buys $63,767 in stock By Investing.com
Robert A. McCabe Jr., a director at National Health Investors Inc. (NASDAQ:NHI), recently purchased 890 shares of the company's common stock for a total of $63,767. This purchase occurred when NHI traded near its 52-week low, and InvestingPro analysis suggests the stock is undervalued. The company additionally boasts a 5.1% dividend yield and has consistently paid dividends for 36 consecutive years.
NATIONAL HEALTH INVESTORS (NYSE: NHI) director adds 890 shares in open-market purchase
NATIONAL HEALTH INVESTORS INC (NYSE: NHI) director Robert A. McCabe Jr. reported an open-market purchase of 890 shares of the company's common stock. The transaction occurred at a price of $71.6485 per share, increasing his direct holdings to 44,158.96 shares. This purchase signals a positive sentiment and a modest increase in his personal investment in NHI.
NHI Maintained by BMO Capital -- Price Target Lowered to $80.00
BMO Capital has maintained an "Outperform" rating for National Health Investors (NHI) but lowered its price target from $90.00 to $80.00 due to cautious market conditions. Despite this, GuruFocus assesses NHI as undervalued with a GF Value™ of $80.24 and a strong GF Score™ of 85/100, citing solid profitability and growth, alongside recent insider buying activity. The article suggests potential for recovery and growth for investors.
BofA Securities Maintains National Health Investors Inc(NHI.US) With Buy Rating, Maintains Target Price $91
BofA Securities has reiterated its Buy rating for National Health Investors Inc (NHI.US), keeping its target price at $91. This indicates a continued positive outlook on the company's stock performance.
Truist cuts National Health Investors stock price target on FFO outlook By Investing.com
Truist Securities has lowered its price target for National Health Investors (NYSE:NHI) to $81 from $89, while maintaining a Buy rating. This adjustment follows a review of the company's 2026 and 2027 funds from operations estimates due to the NHC portfolio sale, which is expected to cause near-term dilution. Despite the reduced price target, Truist highlights the company's strong balance sheet, attractive cost of capital, and consistent dividend payments, suggesting the recent share price pullback could be an entry point for investors.
NATIONAL HEALTH INVESTORS (NHI) director reports bona fide gift of 225 shares
James R. Jobe, a director at National Health Investors (NHI), reported a bona fide gift of 225 shares of Common Stock on June 5, 2026, with a transaction price of $0.00 per share. Following this transaction, Jobe directly holds 33,272 Common Stock shares. This transfer is classified as a neutral filing impact and sentiment, indicating a non-market, no-consideration transfer.
A Look At National Health Investors (NHI) Valuation After Recent Share Price Rebound And Analyst Fair Value Gap
National Health Investors (NHI) has seen its stock rise recently, despite earlier declines, attracting investor attention. Trading at $70.43 against an analyst fair value of $85.75, the company appears undervalued, driven by increased demand for senior housing and rising occupancy rates. However, potential risks include tenant concentration and reliance on equity issuance.
NHI Technical Analysis & Stock Price Forecast
The technical analysis for National Health Investors Inc (NHI) indicates a "Strong Sell" consensus, driven by multiple indicators. The stock is currently trading below its key moving averages, with a 20-Day SMA of $74.079 and a 60-Day SMA of $79.171, against a share price of $70.43. While some oscillators like the Stochastic Oscillator and CCI show buy signals, the MACD, momentum, and most moving averages point towards a bearish outlook.
Insider Buying: D. Mendelsohn Acquires Shares of National Health Investors Inc (NHI)
D. Mendelsohn, CEO and President of National Health Investors Inc (NHI), recently purchased 1,500 shares of the company, bringing his total ownership to 133,316 shares. This transaction marks the only insider buy for NHI in the past year. The current trading price of $68.84 suggests the stock is modestly undervalued compared to its GF Value of $79.97, despite having a price-earnings ratio higher than the industry median and its historical median.
NHI CEO D. Eric Mendelsohn buys $103,260 in company stock
D. Eric Mendelsohn, CEO of National Health Investors Inc. (NHI), purchased 1,500 shares of the company's common stock for $103,260 on June 5, 2026. This acquisition occurred while the stock was trading near its 52-week low and after a recent decline. Following the purchase, Mendelsohn now directly owns 133,316 shares of NHI, a company with a $3.39 billion market cap that has maintained dividend payments for 36 consecutive years.
NHI CEO D. Eric Mendelsohn buys $103,260 in company stock
D. Eric Mendelsohn, CEO of National Health Investors Inc. (NHI), purchased 1,500 shares of company stock for $103,260. This transaction occurred on June 5, 2026, with shares bought at $68.84 each, close to the stock's 52-week low. Mendelsohn now directly owns 133,316 shares in NHI, a company with a $3.39 billion market cap and a 5.39% dividend yield.
NATIONAL HEALTH INVESTORS (NHI) CEO adds 1,500 shares in open-market buy
D. Eric Mendelsohn, CEO and President of National Health Investors (NHI), purchased 1,500 shares of the company's common stock at $68.84 per share in an open-market transaction. This transaction increases his direct ownership to 133,316 shares, reflecting a positive insider sentiment and a small increase in his personal stake. The details were disclosed in an SEC Form 4 filing on June 5, 2026.
National Health Investors Is Maintained at Equal-Weight by Wells Fargo
Wells Fargo has maintained its "Equal-Weight" rating on National Health Investors (NHI), with no change to the price target of $45. This decision follows a detailed review of the company's financial performance and market position by the analyst firm. The "Equal-Weight" rating suggests that Wells Fargo expects National Health Investors to perform in line with the broader market.
NHI (NYSE: NHI) moves 35-facility sale toward expected July 2026 closing
National Health Investors, Inc. (NHI) announced significant progress in the sale of 35 facilities (32 skilled nursing and 3 independent living) to affiliates of National HealthCare Corporation. On May 26, 2026, the Hart-Scott-Rodino antitrust waiting period was terminated early, and the purchaser waived their termination rights, clearing key hurdles. NHI now anticipates closing the transaction around July 1, 2026, though closing remains subject to final conditions.
NHI Stock Price, Quote & Chart | NATL HEALTH INVESTORS INC (NYSE:NHI)
This article provides a detailed overview of National Health Investors Inc. (NHI) stock, including its current price, performance metrics, key statistics, and analyst forecasts. As of June 3, 2026, NHI's stock price is $70.20, down 1.28% today, with analysts projecting a 28.23% price increase over the next year. The company operates in the Health Care REITs sub-industry, specializing in senior housing and medical investments, and has a dividend yield of 4.89%.
National Health Investors, Inc. (NHI) Files Form 8-K with SEC – Key Company Information and Regulatory Details
National Health Investors, Inc. (NHI) announced the results of its 2026 Annual Meeting of Stockholders held on May 27, 2026. Shareholders re-elected directors, approved executive compensation, and ratified BDO USA, P.C. as the independent registered public accounting firm, indicating strong confidence in the company's management and governance. This news suggests stability and positive investor sentiment for the healthcare REIT.
National Health Investors (NHI) stockholders elect full board and ratify BDO
National Health Investors (NHI) held its 2026 Annual Meeting of Stockholders on May 27, 2026, where shareholders elected all seven director nominees, approved executive compensation on an advisory basis, and ratified BDO USA, P.C. as the independent registered public accounting firm for the fiscal year ending December 31, 2026. A quorum of 87.46% of eligible shares was present, and all proposals passed with significant majorities.
National Health Investors Q1 2026 earnings preview
This article provides a preview of National Health Investors' Q1 2026 earnings report. It focuses on the upcoming financial disclosure for the real estate investment trust specializing in healthcare properties.
Understanding Momentum Shifts in (NHI)
This article analyzes momentum shifts for National Health Investors Inc. (NHI) using AI-generated signals. It outlines near-term strong sentiment, mid-term neutrality, and a long-term positive bias, noting elevated downside risk due to a lack of long-term support signals. The analysis also provides three distinct institutional trading strategies—Position Trading, Momentum Breakout, and Risk Hedging—with specific entry, target, and stop-loss levels.
BofA Securities Maintains National Health Investors Inc(NHI.US) With Buy Rating, Raises Target Price to $91
BofA Securities has reiterated its Buy rating for National Health Investors Inc (NHI.US) and increased the target price to $91. This indicates continued confidence in the company's performance and future outlook from the investment firm.
The Bull Case For National Health Investors (NHI) Could Change Following Q1 2026 Beat And New Guidance
National Health Investors (NHI) reported a strong first quarter in 2026, with higher-than-expected revenue and net income guidance for the full year, reaching approximately US$703.00 million to US$705.20 million. Despite these positive financial results and a maintained quarterly dividend of US$0.92 per share, the company's investment narrative still hinges on improving occupancy and managing tenant and portfolio volatility. The article highlights that while the new guidance offers better visibility, key risks remain, and investors should consider diverse viewpoints on NHI's fair value.
The Bull Case For National Health Investors (NHI) Could Change Following Q1 2026 Beat And New Guidance
National Health Investors (NHI) reported a strong Q1 2026 with sales of US$73.15 million and net income of US$40.10 million, along with a US$0.92 per share dividend. The company also issued full-year 2026 net income guidance of US$703.0 million to US$705.2 million, which provides clearer profitability expectations. While these results and guidance support the investment narrative, the core risks of occupancy and tenant performance volatility remain, as does the concentration in a few key operators.
NHI SEC Filings - National Health Investors 10-K, 10-Q, 8-K Forms
This article compiles recent SEC filings for National Health Investors (NHI), detailing insider stock transactions, quarterly financial results, and future outlooks. Key filings include an SVP receiving a restricted stock award, initial Form 3 filings for new officers/directors, and comprehensive reports outlining strong projected 2026 FFO and SHOP NOI growth, Q4 2025 financial performance, and the company's capital structure and revenue streams. The filings also address key risks and the company's investment strategy in senior housing and medical facilities.
VIRGINIA RETIREMENT SYSTEMS ET Al Has $3.80 Million Stock Holdings in National Health Investors, Inc. $NHI
Virginia Retirement Systems ET Al reduced its stake in National Health Investors (NHI) by 42.8% in Q4, holding 49,800 shares valued at $3.8 million. Despite missing Q1 earnings estimates with $0.82 EPS, the company's revenue increased by 28.9% year-over-year to $115.13 million. Analysts rate NHI as a "Moderate Buy" with a consensus price target of $87.50, and the company declared a quarterly dividend of $0.92 per share.
